Other reports have demonstrated that silencing of SOCS1 can enhance the anti-tumor activity of type I or type II IFNs by regulating apoptosis in neuroendocrine tumor cells [41]. This evidence concerns the gene SOCS1 and neuroendocrine neoplasm.